Perioperative pembrolizumab or placebo plus neoadjuvant cisplatin and gemcitabine in participants with muscle-invasive bladder cancer who are eligible for cisplatin: the double-blind, phase III KEYNOTE-866 study
Publication date: Available online 23 October 2026 Source: Annals of Oncology Author(s): J. Bedke, P. Arkosy, H. Nishiyama, H. Mahammedi, C. Vulsteke, M.J. Juan-Fita, I. Antonyan, O. Didas, E. Verzoni, V. Atduev, A. Rodriguez-Vida, J.J. Oh, S.-H. Kang, A. Peer, R. Zukov, B. Zurawksi, M. Gümüş, G.D. Steinberg, J. Olah, S. Abadie-Lacourtoisie
Perioperative pembrolizumab or placebo plus neoadjuvant cisplatin and gemcitabine in participants with muscle-invasive bladder cancer who are eligible for cisplatin: the double-blind, phase III KEYNOTE-866 study. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426068882?dgcid=rss_sd_all
Perioperative pembrolizumab or placebo plus neoadjuvant cisplatin and gemcitabine in participants with muscle-invasive bladder cancer who are eligible for cisplatin: the double-blind, phase III KEYNOTE-866 study. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426068882?dgcid=rss_sd_all
“Perioperative pembrolizumab or placebo plus neoadjuvant cisplatin and gemcitabine in participants with muscle-invasive bladder cancer who are eligible for cisplatin: the double-blind, phase III KEYNOTE-866 study.” Annals of Oncology.
@article{article36295,
title = {Perioperative pembrolizumab or placebo plus neoadjuvant cisplatin and gemcitabine in participants with muscle-invasive bladder cancer who are eligible for cisplatin: the double-blind, phase III KEYNOTE-866 study},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426068882?dgcid=rss_sd_all}
}
ABSTRACT Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study...
Abstract Background and Objectives Perioperative blood transfusion in hip arthroplasty is associated with increased morbidity, prolonged hospitalization, and higher costs. This study aimed to identify independent risk factors and...